Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 749

1.

Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa.

Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS; ACTA Trial Study Team.

N Engl J Med. 2018 Mar 15;378(11):1004-1017. doi: 10.1056/NEJMoa1710922.

2.

Failure of fluconazole in treating cutaneous leishmaniasis caused by Leishmania guyanensis in the Brazilian Amazon: An open, nonrandomized phase 2 trial.

Francesconi VA, Francesconi F, Ramasawmy R, Romero GAS, Alecrim MDGC.

PLoS Negl Trop Dis. 2018 Feb 26;12(2):e0006225. doi: 10.1371/journal.pntd.0006225. eCollection 2018 Feb.

3.

Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.

Palma E, Recine N, Domenici L, Giorgini M, Pierangeli A, Panici PB.

BMC Infect Dis. 2018 Jan 5;18(1):13. doi: 10.1186/s12879-017-2938-z.

4.

Fluconazole-loaded solid lipid nanoparticles topical gel for treatment of pityriasis versicolor: formulation and clinical study.

El-Housiny S, Shams Eldeen MA, El-Attar YA, Salem HA, Attia D, Bendas ER, El-Nabarawi MA.

Drug Deliv. 2018 Nov;25(1):78-90. doi: 10.1080/10717544.2017.1413444.

PMID:
29239242
5.

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.

Hakim J, Musiime V, Szubert AJ, Mallewa J, Siika A, Agutu C, Walker S, Pett SL, Bwakura-Dangarembizi M, Lugemwa A, Kaunda S, Karoney M, Musoro G, Kabahenda S, Nathoo K, Maitland K, Griffiths A, Thomason MJ, Kityo C, Mugyenyi P, Prendergast AJ, Walker AS, Gibb DM; REALITY Trial Team.

N Engl J Med. 2017 Jul 20;377(3):233-245. doi: 10.1056/NEJMoa1615822.

6.

Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.

Kontoyiannis DP, Bassetti M, Nucci M, Capparella MR, Yan JL, Aram J, Hogan PA.

Mycoses. 2017 Oct;60(10):663-667. doi: 10.1111/myc.12641. Epub 2017 Jun 9.

PMID:
28597967
7.

Drug-drug interaction of microdose and regular-dose omeprazole with a CYP2C19 inhibitor and inducer.

Park GJ, Bae SH, Park WS, Han S, Park MH, Shin SH, Shin YG, Yim DS.

Drug Des Devel Ther. 2017 Mar 30;11:1043-1053. doi: 10.2147/DDDT.S131797. eCollection 2017.

8.

Efficacy of vitamin B complex as an adjuvant therapy for the treatment of complicated vulvovaginal candidiasis: An in vivo and in vitro study.

Sun MG, Huang Y, Xu YH, Cao YX.

Biomed Pharmacother. 2017 Apr;88:770-777. doi: 10.1016/j.biopha.2017.01.001. Epub 2017 Jan 31.

PMID:
28157653
9.

Effects of cytochrome P450 (CYP3A4 and CYP2C19) inhibition and induction on the exposure of selumetinib, a MEK1/2 inhibitor, in healthy subjects: results from two clinical trials.

Dymond AW, So K, Martin P, Huang Y, Severin P, Mathews D, Lisbon E, Mariani G.

Eur J Clin Pharmacol. 2017 Feb;73(2):175-184. doi: 10.1007/s00228-016-2153-7. Epub 2016 Nov 26.

10.

Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.

Yang L, Cheriyan J, Gutterman DD, Mayer RJ, Ament Z, Griffin JL, Lazaar AL, Newby DE, Tal-Singer R, Wilkinson IB.

Chest. 2017 Mar;151(3):555-563. doi: 10.1016/j.chest.2016.10.058. Epub 2016 Nov 21.

11.

Low Caspofungin Exposure in Patients in Intensive Care Units.

van der Elst KC, Veringa A, Zijlstra JG, Beishuizen A, Klont R, Brummelhuis-Visser P, Uges DR, Touw DJ, Kosterink JG, van der Werf TS, Alffenaar JC.

Antimicrob Agents Chemother. 2017 Jan 24;61(2). pii: e01582-16. doi: 10.1128/AAC.01582-16. Print 2017 Feb.

12.

Fluconazole in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis: A Randomized Controlled Trial.

Prates FV, Dourado ME, Silva SC, Schriefer A, Guimarães LH, Brito MD, Almeida J, Carvalho EM, Machado PR.

Clin Infect Dis. 2017 Jan 1;64(1):67-71. Epub 2016 Nov 1.

PMID:
27803094
13.

[Candiduria! What now? : Therapy of urinary tract infections with Candida].

Hof H.

Urologe A. 2017 Feb;56(2):172-179. doi: 10.1007/s00120-016-0219-x. German.

PMID:
27590778
14.
15.

[Tinea in the genital area : A diagnostic and therapeutic challenge].

Ginter-Hanselmayer G, Nenoff P, Kurrat W, Propst E, Durrant-Finn U, Uhrlaß S, Weger W.

Hautarzt. 2016 Sep;67(9):689-99. doi: 10.1007/s00105-016-3848-5. German.

PMID:
27488308
16.

Population Pharmacokinetics of Fluconazole in Premature Infants with Birth Weights Less than 750 Grams.

Momper JD, Capparelli EV, Wade KC, Kantak A, Dhanireddy R, Cummings JJ, Nedrelow JH, Hudak ML, Mundakel GT, Natarajan G, Gao J, Laughon M, Smith PB, Benjamin DK Jr.

Antimicrob Agents Chemother. 2016 Aug 22;60(9):5539-45. doi: 10.1128/AAC.00963-16. Print 2016 Sep.

17.

Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.

Park S, Kim K, Jang JH, Kim SJ, Kim WS, Chung DR, Kang CI, Peck KR, Jung CW.

J Infect. 2016 Nov;73(5):496-505. doi: 10.1016/j.jinf.2016.06.011. Epub 2016 Jul 7.

PMID:
27394404
18.

Oral care in a neonatal intensive care unit.

Fernandez Rodriguez B, Peña Gonzalez L, Calvo MC, Chaves Sanchez F, Pallas Alonso CR, de Alba Romero C.

J Matern Fetal Neonatal Med. 2017 Apr;30(8):953-957. doi: 10.1080/14767058.2016.1192599. Epub 2016 Jun 17.

PMID:
27242010
19.

Comparing the Recurrence of Vulvovaginal Candidiasis in Patients Undergoing Prophylactic Treatment with Probiotic and Placebo During the 6 Months.

Davar R, Nokhostin F, Eftekhar M, Sekhavat L, Bashiri Zadeh M, Shamsi F.

Probiotics Antimicrob Proteins. 2016 Sep;8(3):130-3. doi: 10.1007/s12602-016-9218-x.

PMID:
27206514
20.

A clinical drug-drug interaction study to evaluate the effect of a proton-pump inhibitor, a combined P-glycoprotein/cytochrome 450 enzyme (CYP)3A4 inhibitor, and a CYP2C9 inhibitor on the pharmacokinetics of vismodegib.

Malhi V, Colburn D, Williams SJ, Hop CE, Dresser MJ, Chandra P, Graham RA.

Cancer Chemother Pharmacol. 2016 Jul;78(1):41-9. doi: 10.1007/s00280-016-3020-z. Epub 2016 May 6.

Supplemental Content

Loading ...
Support Center